학술논문

Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT)
Document Type
Article
Source
In: npj Breast Cancer. (npj Breast Cancer, December 2022, 8(1))
Subject
Language
English
ISSN
23744677